))
Introducing a New Podcast from AMERSA and the ATTC Network! AMERSA is proud to announce a new podcast exploring the world of substance use education, research, care and policy! “AMERSA People & Passion” is a 10-episode series sponsored by the ATTC Network and hosted by executive director Doreen Bader, featuring subject matter experts across a variety of topics, as well as special guests detailing their experiences as AMERSA members. You can listen to new episodes of the podcast every week be ...
…
continue reading
To support utilization of Medications for Opioid Use Disorder (MOUD), the Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA) team will be releasing a mobile application that will guide healthcare providers through the initiation of buprenorphine and naltrexone for OUD (including injectable buprenorphine) and pain manageme…
…
continue reading
1
History of AMERSA with Sid Schnoll
1:14:01
1:14:01
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:14:01
Sid Schnoll, one of the founders of AMERSA, discusses with Paul Lum the origin of the organization out of the Career Teacher Program of the early 1970s. The desire by the federal government to cultivate experts in substance use disorders into health professional schools has resulted in a vibrant, growing organization that helps health educators pro…
…
continue reading
1
Key Conversations: Dismantling Racism Against Black, Indigenous, and People of Color Across the Substance Use Continuum
37:30
The Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA) released a solidarity statement and a position paper articulating racism’s deadly effects on persons who use alcohol, tobacco, and other drugs. This cascade of negative effects, compounded with the social determinants of health results in higher rat…
…
continue reading
Substance Use Disorders are common in people with serious illness and contribute immensely to suffering and poor quality of life. People with addiction and serious illness are an underserved population with unmet and complex medical and psychosocial needs. In this episode, Palliative care clinicians will discuss the overlap between both fields, edu…
…
continue reading
The COVID-19 pandemic is distinct from other catastrophic events because of massive population exposure to ongoing trauma. Illness, death, loss, grief, job- and food-insecurity have led to increased substance use, return to use/relapse, overdose and death. In the face of widespread misinformation, accurate and engaging health messaging matters NOW …
…
continue reading
The episode highlights peers in an acute care setting engaging with vulnerable patients suffering from active substance use disorder, with a focus on the intersection of lived experience, evidence-based treatment, and harm reduction strategies. Paul Bowman, Colleen LaBelle, and Nicole O'Donnell speak about the safe space a peer creates in an enviro…
…
continue reading
Join AMERSA and ATTC in celebrating a journey through AMERSA time with Marianne Marcus, in conversation with Sid Schnoll. This podcast summarizes Dr. Marianne Marcus’ career as a nurse educator and researcher, and the role AMERSA played in developing her understanding of substance use disorders. Her career included sequential faculty positions in H…
…
continue reading
1
Barriers to Treatment for Opioid Use Disorder: Why Aren’t Pharmacists Stocking Buprenorphine?
40:27
Patients with opioid use disorder must be able to obtain prescribed buprenorphine from a pharmacy promptly to reduce risk for a recurrence of use and subsequent morbidity and mortality. However, phone-based secret shopper surveys indicate many pharmacies do not consistently maintain an adequate stock of buprenorphine and qualitative surveys show so…
…
continue reading
One major barrier to accomplishing a healthcare system that incorporates prevention, early identification, treatment and recovery is the stigma experienced by people with substance use disorders. While we know how to define stigma and how it impacts individuals and families, how we eliminate stigma specifically in healthcare settings to improve car…
…
continue reading
In this podcast Rich Saitz, former AMERSA President, is interviewed by Nic Bertholet, discussing whether screening and brief intervention is effective, and what the controversy is. We learn about the evidence, what research should still be done, what we should teach, what we should do in practice, and how it has loomed large at AMERSA.…
…
continue reading
